Pilot Study of the Effect of Adalimumab on Physical Function and Musculoskeletal Disease in Mucopolysaccharidosis Types I, II and VI
Phase of Trial: Phase I/II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Mucopolysaccharidosis I; Mucopolysaccharidosis II; Mucopolysaccharidosis IV
- Focus Therapeutic Use
- 16 Aug 2017 Status changed from recruiting to completed.
- 20 May 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
- 14 May 2015 New trial record